Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Sarcopenia × durvalumab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Sarcopenia 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1

Interventions

pembrolizumab 1 durvalumab 1 atezolizumab 1 Standard of Care 1 Preoperative Exercise 1 Olive Oil 1 Nivolumab 1 Immune Checkpoint Inhibitors 1 Docosahexaenoic Acids 1 Chemotherapy, Adjuvant 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07192926 2026-02-20

SARCO-CTI

Ankara Etlik City Hospital

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡